Patrick Roussel,Jutta Heim,Peter Schneider,Christian Bartels,Yaoquan Liu,Glenn Dale,Daniel Milligan
申请号：
US15952616
公开号：
US10517865B2
申请日:
2018.04.13
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein are compounds of Formula Iwherein R1, R2, X, and Y are defined herein. These compounds are type II topoisomerase inhibitors and can be used in methods for treating infections caused by gram-positive pathogens, gram-negative pathogens, and drug-resistant strains thereof.
